Agnes Vitry, Senior Research Fellow, School of Pharmacy and Medical Sciences, University of South Australia, has sent in this detailed, thoughtful response to the recent Croakey survey on the issues surrounding the controversial, commercially-funded Australian and NZ guidelines for blood clot prevention (for more background, see previous Croakey posts).
Vitry’s comments are well worth a read:
1. [...]
-
Pages
-
Categories
- adverse events
- alcohol
- Australian Medical Association
- cancer
- child health
- childbirth and maternity services
- chronic diseases
- climate change
- Cochrane Collaboration
- complementary medicines
- conflicts of interest
- consumer health information
- Crikey register of influence
- Croakey Register of Unreleased Documents
- dental care
- e-health
- education
- environmental health
- evidence-based issues
- Federal Budget 2009-2010
- Food
- general practice
- global health
- health & medical marketing
- health and medical education
- health and medical research
- health ethics
- health financing and costs
- Health inequalities
- health reform
- health regulation
- health workforce
- Hospitals
- HRT
- illicit drugs
- Indigenous education
- Indigenous health
- infectious diseases
- influenza
- international medical graduates
- Journal articles
- legal issues
- Media-related issues
- medical education
- men's health
- mental health
- NHMRC
- NT Intervention
- nurses and nursing
- obesity
- pathology
- pharmaceutical industry
- pharmacy
- physical activity
- poverty
- prevention
- primary health care
- private health insurance
- public health
- quality and safety of health care
- rural and remote health
- screening
- surgery
- swine flu
- tests
- TGA
- tobacco control
- trauma
- Uncategorized
- weight loss products
-
Archives
